Your browser doesn't support javascript.
loading
Outcomes of blinatumomab based therapy in children with relapsed, persistent, or refractory acute lymphoblastic leukemia: a multicenter study focusing on predictors of response and post-treatment immunoglobulin production.
Essa, Mohammed F; Abdellatif, Reem; Elimam, Naglla; Ballourah, Waleed; Alsudairy, Reem; Alkaiyat, Mohammad; Alsultan, Abdulrahman; Jastaniah, Wasil.
Afiliación
  • Essa MF; Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children's Hospital, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Abdellatif R; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Elimam N; King Abdullah International Medical Research Center, National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Ballourah W; Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children's Hospital, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Alsudairy R; King Abdullah International Medical Research Center, National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Alkaiyat M; Department of Oncology, Princess Noorah Oncology Center, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
  • Alsultan A; Department of Pediatric Hematology/Oncology, Comprehensive Cancer Center, King Fahd Medical City, Riyadh, Saudi Arabia.
  • Jastaniah W; Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children's Hospital, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Pediatr Hematol Oncol ; 39(7): 613-628, 2022 Oct.
Article en En | MEDLINE | ID: mdl-36200934

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Linfoma de Células B / Infecciones por Virus de Epstein-Barr / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Pediatr Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Linfoma de Células B / Infecciones por Virus de Epstein-Barr / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Pediatr Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita